论文部分内容阅读
目的评估同时行经尿道膀胱肿瘤电切(TURBT)和前列腺汽化切除(TUVP)治疗非肌层浸润性膀胱肿瘤合并有严重下尿路症状前列腺增生患者的疗效。方法对2004年至2008年期间45例行TURBT+TUVP和126例单纯行TURBT的非肌层浸润性膀胱肿瘤患者的肿瘤复发率、进展率和后尿道种植率进行比较。结果TURBT+TUVP组的肿瘤复发率、进展率和后尿道种植率分别为26.7%、8.9%和4.4%;TURBT组分别为27.8%、8.7%和4.8%,两组比较差异无统计学意义(P>0.05)。结论同时行TURBT+TUVP治疗非肌层浸润性膀胱肿瘤合并有严重下尿路症状的前列腺增生患者是安全、有效的。
Objective To evaluate the efficacy of concurrent transurethral resection of bladder tumor (TURBT) and transurethral resection of the prostate (TUVP) in the treatment of benign prostatic hyperplasia in patients with non-muscle invasive bladder tumor complicated by lower urinary tract. Methods Tumor recurrence rate, progression rate and posterior urethral implantation rate were compared between 45 TURBT + TUVP patients and 126 TURBT non-muscle invasive bladder tumors from 2004 to 2008. Results The tumor recurrence rate, progression rate and posterior urethral implantation rate in TURBT + TUVP group were 26.7%, 8.9% and 4.4% respectively, while those in TURBT group were 27.8%, 8.7% and 4.8% respectively. There was no significant difference between the two groups P> 0.05). Conclusions TURBT + TUVP is safe and effective in the treatment of benign prostatic hyperplasia in patients with non-muscle invasive bladder tumor complicated with lower urinary tract symptoms.